In 2014, Kong provided the direct evidence of miR-30c specific binding to the 3' UTP of MTA-1(Metastasis Associated 1), which further demonstrated that miR-30c was negatively related with endometrial cancer progression through MTA-1 inhibition 40. The gene discussed is MTA1; the disease is endometrial cancer.